Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Assess Safety and Tolerability of Amicidin-β Topical Solution in Adult Patients Undergoing Interventional Management of a Surgical or Traumatic Wound Infection

NCT07379684 is registered in ClinicalTrials.gov with Macro Biologics, Inc. as lead sponsor.

NCT NCT07379684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Assess Safety and Tolerability of Amicidin-β Topical Solution in Adult Patients Undergoing Interventional Management of a Surgical or Traumatic Wound Infection
Lead sponsor
Macro Biologics, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
September 30, 2026
Completion date
February 28, 2027
Enrollment
44 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

surgical wound infection, traumatic wound infection